Search research articles
Contact Us
Filters
Showing results (1-10 of 119) with videos related to
Page
of 12
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 30, 2011
Rapid dopamine signaling differentially modulates distinct microcircuits within the nucleus accumbens during sucrose-directed behavior
Fabio Cacciapaglia, R Mark Wightman, Regina M Carelli
Journal of Scleroderma and Related Disorders
|
June 8, 2023
Subcutaneous immunoglobulin therapy for refractory skin thickening in rapidly progressive systemic sclerosis: A case report and literature review
Fabio Cacciapaglia, Stefano Stano, Marco Fornaro, et al.
The Journal of Rheumatology
|
January 16, 2022
Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases
Marco Fornaro, Vincenzo Venerito, Florenzo Iannone, et al.
Endocrine
|
February 14, 2012
The use of a glucose spray device to control progression towards hypoglycaemia
Yeganeh Manon Khazrai, Fabio Cacciapaglia, Andrea Palermo, et al.
Psychopharmacology
|
July 20, 2006
Monitoring extracellular dopamine in the rat nucleus accumbens shell and core during acquisition and maintenance of intravenous WIN 55,212-2 self-administration
Daniele Lecca, Fabio Cacciapaglia, Valentina Valentini, et al.
Annals of the Rheumatic Diseases
|
October 13, 2019
Response to: 'Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro <i>et al</i>' by Agca <i>et al</i>
Marco Fornaro, Fabio Cacciapaglia, Vincenzo Venerito, et al.
Rheumatology (Oxford, England)
|
January 4, 2020
Phosphorylated signal transducer and activator of transcription 3 (pSTAT3) is highly expressed in CD14+ circulating cells of scleroderma patients
Fabio Cacciapaglia, Simone Perniola, Livio Urso, et al.
Drug Development Research
|
November 11, 2014
The use of an interferon-gamma release assay as a biomarker of response to anti-TNF-alpha treatment
Fabio Cacciapaglia, Francesca Buzzulini, Luisa Arcarese, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
January 3, 2019
Splenic Infarction as Only Manifestation of Antiphospholipid Syndrome in a Patient With Rheumatoid Arthritis
Vincenzo Venerito, Giuseppe Lopalco, Fabio Cacciapaglia, et al.
Cardiovascular Toxicology
|
May 7, 2014
Low level tumor necrosis factor-alpha protects cardiomyocytes against high level tumor necrosis factor-alpha: brief insight into a beneficial paradox
Fabio Cacciapaglia, Emanuela Salvatorelli, Giorgio Minotti, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 119) with videos related to
Sort By:
Page
of 12
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 30, 2011
Rapid dopamine signaling differentially modulates distinct microcircuits within the nucleus accumbens during sucrose-directed behavior
Fabio Cacciapaglia, R Mark Wightman, Regina M Carelli
Journal of Scleroderma and Related Disorders
|
June 8, 2023
Subcutaneous immunoglobulin therapy for refractory skin thickening in rapidly progressive systemic sclerosis: A case report and literature review
Fabio Cacciapaglia, Stefano Stano, Marco Fornaro, et al.
The Journal of Rheumatology
|
January 16, 2022
Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases
Marco Fornaro, Vincenzo Venerito, Florenzo Iannone, et al.
Endocrine
|
February 14, 2012
The use of a glucose spray device to control progression towards hypoglycaemia
Yeganeh Manon Khazrai, Fabio Cacciapaglia, Andrea Palermo, et al.
Psychopharmacology
|
July 20, 2006
Monitoring extracellular dopamine in the rat nucleus accumbens shell and core during acquisition and maintenance of intravenous WIN 55,212-2 self-administration
Daniele Lecca, Fabio Cacciapaglia, Valentina Valentini, et al.
Annals of the Rheumatic Diseases
|
October 13, 2019
Response to: 'Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro <i>et al</i>' by Agca <i>et al</i>
Marco Fornaro, Fabio Cacciapaglia, Vincenzo Venerito, et al.
Rheumatology (Oxford, England)
|
January 4, 2020
Phosphorylated signal transducer and activator of transcription 3 (pSTAT3) is highly expressed in CD14+ circulating cells of scleroderma patients
Fabio Cacciapaglia, Simone Perniola, Livio Urso, et al.
Drug Development Research
|
November 11, 2014
The use of an interferon-gamma release assay as a biomarker of response to anti-TNF-alpha treatment
Fabio Cacciapaglia, Francesca Buzzulini, Luisa Arcarese, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
January 3, 2019
Splenic Infarction as Only Manifestation of Antiphospholipid Syndrome in a Patient With Rheumatoid Arthritis
Vincenzo Venerito, Giuseppe Lopalco, Fabio Cacciapaglia, et al.
Cardiovascular Toxicology
|
May 7, 2014
Low level tumor necrosis factor-alpha protects cardiomyocytes against high level tumor necrosis factor-alpha: brief insight into a beneficial paradox
Fabio Cacciapaglia, Emanuela Salvatorelli, Giorgio Minotti, et al.
Page
of 12